ABSTRACT: The HIV-1 fusion peptide serves as a useful model system for understanding viral/target cell fusion, at least to the lipid-mixing stage. Previous solid-state NMR studies have shown that the membranebound HIV-1 fusion peptide adopts an extended conformation in a lipid mixture close to that of host cells of the virus. In the present study, solid-state NMR REDOR methods were applied for detection of oligomeric strand structure. The samples were prepared under fusogenic conditions and contained equimolar amounts of two peptides, one with selective [ 13 C]carbonyl labeling and the other with selective [ 15 N]amide labeling. In the REDOR measurements, observation of reduced 13 C intensity due to hydrogen-bonded amide 15 N provides strong experimental evidence of oligomer formation by the membrane-associated peptide.
Fusion between the membranes of enveloped viruses such as HIV-1 1 and influenza and the membranes of their target host cells is an essential step in infection (1) (2) (3) (4) . For these viruses, this process is mediated by integral membrane viral envelope proteins which contain N-terminal ∼20-residue apolar fusion peptide domains. For HIV-1 and influenza, the free fusion peptide has also been shown to be a useful model to understand fusion, at least to the lipid-mixing stage. The free peptide causes fusion of liposomes and erythrocytes, and numerous mutational studies have shown strong correlations between fusion peptide-induced liposome fusion and viral/host cell fusion (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Recent studies suggest that envelope protein regions other than the fusion peptide also interact with membranes and play a role in fusion (21) (22) (23) (24) (25) (26) .
There is a crystal structure of the part of the influenza hemagglutinin envelope protein which lies outside the virus and which contains the fusion peptide (27) . This "ectodomain" structure corresponds to a prefusogenic conformation. For both the hemagglutinin and the HIV-1 gp41 envelope proteins, there are also atomic resolution structures of the "soluble ectodomains" which do not contain the fusion peptide (28) (29) (30) (31) (32) (33) (34) . These structures are believed to correspond to the protein conformations after fusion has occurred and perhaps during fusion as well. In each of these soluble ectodomain structures, the protein is trimeric, and its three N-termini (corresponding to about residue 30 in the whole envelope protein) are in close proximity at the end of an in-register helical coiled-coil. These structures end several residues C-terminal of the fusion peptide, and it has therefore been hypothesized that during viral/target cell fusion, at least three fusion peptides insert into the target cell membrane with their C-termini in close proximity.
A variety of experimental methods have shown that both the HIV-1 and influenza fusion peptides can assume helical or nonhelical structures in their membrane-associated forms (6, 9, 10, 14, 15, 17, 18, (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) . Models for the helical structure have been developed on the basis of nuclear † This work was supported in part by a Camille and Henry Dreyfus Foundation New Faculty Award, by NIH Award R01-AI47153, and by NSF Award 9977650 to D.P.W. A Michigan State University Center for Biological Modeling fellowship provided partial financial support for J.Y.
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Fluorescence and ESR data also suggest that the nonhelical HIV-1 peptides form oligomeric structures (16, 20, 35) . The possible significance of fusion peptide oligomerization is suggested both by envelope protein trimerization and by experiments and modeling studies which indicate that the fusion site contains multiple trimers and a corresponding high fusion peptide concentration (31, 32, (59) (60) (61) . In addition, the functionally disruptive Val-2 to Glu-2 mutation in the gp41 fusion peptide is trans-dominant; i.e., cells expressing 10% mutant protein and 90% wild-type protein exhibit only 40% of the fusion activity of cells with 100% wild-type protein (8) . One interpretation of these data is that the mutant peptide disrupts the correct assembly of a functionally important fusion peptide oligomer (16, 20) .
Previous solid-state NMR studies on the HIV-1 fusion peptide demonstrated that the peptide adopts a predominantly strand structure when associated with membranes whose lipid headgroup and cholesterol composition is comparable to that found in host cells of the virus (45) . One strength of the solid-state NMR approach is that membrane-associated peptide samples can be prepared under fusogenic conditions. In the present study, oligomeric structure in the membranebound HIV-1 fusion peptide was investigated using solidstate NMR methods which probe interpeptide hydrogen bonding. In these experiments, rotational-echo double resonance (REDOR) spectroscopy was applied to samples containing a 1:1 mixture of [
13 C]carbonyl-labeled peptide and [ 15 N]amide-labeled peptide. In the REDOR experiment, 13 C-15 N dipolar couplings were measured and then related to r CN distances and interpeptide hydrogen bonding through the r -3 dependence of the dipolar coupling (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) . In addition, the relative populations and structures of parallel and antiparallel strand arrangements in the oligomers were probed using a variety of samples which differed by the residue positions of the 13 C labeling in one peptide and/or the 15 N labeling in the other peptide. The REDOR experiments demonstrate the presence of a large population of membrane-associated fusion peptide oligomers with approximately equal weighting of parallel and antiparallel strand arrangements.
MATERIALS AND METHODS

Materials.
Rink amide resin was purchased from Advanced Chemtech (Louisville, KY), and 9-fluorenylmethoxycarbonyl (FMOC) amino acids were obtained from Peptides International (Louisville, KY). 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-snglycero-3-phospho-L-serine (POPS), phosphatidylinositol (PI), sphingomyelin, [1-13 C]-1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC-1-13 C), N-(7-nitro-2,1,3-benzoxadiazol-4-yl)phosphatidylethanolamine (N-NBD-PE), N-(lissamine rhodamine B sulfonyl)phosphatidylethanolamine (NRh-PE), and cholesterol were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). The Micro BCA protein assay was obtained from Pierce (Rockford, IL). N-(2-Hydroxyethyl)piperazine-N′-2-ethanesulfonic acid (HEPES) and Triton X-100 were obtained from Sigma. All other reagents were of analytical grade. The buffer solution used in the study contained 5 mM HEPES (pH 7.0) with 0.01% NaN 3 .
Peptides. FP peptides corresponding to the 23 N-terminal residues (sequence AVGIGALFLGFLGAAGSTMGARS) of the LAV 1a strain of HIV-1 gp41 were synthesized as their C-terminal amides using a peptide synthesizer (ABI 431A, Foster City, CA) equipped for FMOC chemistry. FP was either unlabeled (FP-unlabeled), triply [ 13 As will be shown in the Results section, FP and FPK3 have comparable fusion activities and adopt similar membraneassociated structures. They are also both soluble at ∼100 µM concentration in 5 mM pH 7 HEPES buffer. In practical terms, the chief advantage of FPK3 is that it dissolves more quickly in buffer than FP.
FPK3W-F8 C L9 N (sequence AVGIGALFLGFLGAAGST-MGARSKKKW) was synthesized with a [ 13 After synthesis, peptides were cleaved from the resin in a 3 h reaction using a mixture of TFA-H 2 O-phenolthioanisole-ethanedithiol in a 33:2:2:2:1 volume ratio. Peptides were subsequently purified by reversed-phase HPLC using a preparative C 18 column (Vydac, Hesperia, CA) and a water-acetonitrile gradient containing 0.1% TFA. Mass spectroscopy was used for peptide identification.
For the labeled peptide syntheses, labeled amino acids were purchased from Icon Services Inc. (Summit, NJ) and were FMOC-protected using literature methods (74, 75) . In addition, [1-13 C, 15 N]glycine and [2-13 C, 15 N]glycine samples were prepared by aqueous dissolution of a 1:9 mixture of labeled:unlabeled glycine followed by crystallization by slow evaporation of the water.
Lipid Preparation. Samples were prepared using lipid/ cholesterol mixtures reflecting the approximate lipid headgroup and cholesterol content of host cells of the virus (76) .
Two such mixtures were used: (a) "LM3" had POPC, POPE, POPS, sphingomyelin, PI, and cholesterol in a 10:5:2:2:1: 10 mole ratio; (b) "LM4" had DPPC-1-13 C, POPE, POPS, sphingomyelin, PI, and cholesterol in a 10:5:2:2:1:10 mole ratio. Thus, in LM4, 50% of the lipid molecules were [ 13 C]-carbonyl labeled. Lipid and cholesterol powders were dissolved together in chloroform. The chloroform was removed under a stream of nitrogen followed by overnight vacuum pumping. Lipid dispersions were formed by addition of 5 mM pH 7.0 HEPES, followed by homogenization with 10 freeze-thaw cycles. Large unilamellar vesicles (LUVs) of 100 nm diameter were prepared by extrusion (77) .
Lipid-Mixing Assay of Membrane Fusion. The resonance energy transfer (RET) assay was used to monitor membrane fusion (78) . Two types of 100 nm diameter LM3 LUVs were prepared. One set contained 2 mol % of the fluorescent lipid N-NBD-PE and 2 mol % of the quenching lipid N-Rh-PE while the other set only contained unlabeled lipids. Fluorescently labeled and unlabeled vesicles were mixed in a 1:9 ratio. Following addition of the fusion peptide, lipid mixing between labeled and unlabeled vesicles caused dilution of the labeled lipids with a resulting increase of fluorescence. Fluorescence was recorded using 4 nm bandwidth on a Instruments S.A. Fluoromax-2 spectrofluorometer (Edison, NJ) operating at excitation and emission wavelengths of 465 and 530 nm, respectively. A siliconized glass cuvette was used with continuous stirring in a thermostated cuvette holder. Measurements were carried out at 37°C with 2 mL of 150 µM LUVs in buffer solution. The initial residual fluorescence intensity, F 0 , referenced zero lipid mixing. After quantitation of the peptide concentrations with amino acid analysis, the requisite volume of 100 µM FP or FPK3 peptide in 5 mM pH 7.0 HEPES was added to achieve the desired peptide:lipid mole ratio, and the fluorescence (F t ) of the sample was monitored as a function of time following this addition. The maximum fluorescence intensity, F max , was obtained following addition of 10 µL of 20% Triton X-100. F t and F max were corrected for the small fluorophore dilution resulting from the added volumes of peptide and Triton X-100. Percent lipid mixing at time t is denoted as M t and was calculated using With sufficient time, M t reached a constant value which is denoted as M f , the final extent of lipid mixing. M f was used as an approximate measure of peptide fusogenicity. For a given set of labeled and unlabeled vesicles, M f had (2% reproducibility between different assay trials.
Solid-State NMR Sample Preparation. Peptide was dissolved in ∼35 mL of 5 mM HEPES, pH 7.0. Peptide concentrations were determined by the BCA assay which had been calibrated using quantitative amino acid analysis. For samples containing two differently labeled peptides, each peptide was dissolved separately and the two solutions were then combined. LUVs of LM3 or LM4 (40 µmol of lipid + 20 µmol of cholesterol) were prepared in ∼2 mL of buffer. The peptide and LUV solutions were then mixed and kept at room temperature overnight to ensure maximum peptide/ lipid binding. Subsequent ultracentrifugation of the solution at 100000g for 4 h pelleted the membrane and associated bound peptide and left unbound peptide in the supernatant.
Peptide binding was typically quantitative as determined by BCA assay measurements of negligible peptide concentration in the supernatant. The peptide/lipid pellet formed after ultracentrifugation was transferred by spatula to a 6 mm diameter magic angle spinning (MAS) NMR rotor. In the absence of LUVs, FP did not pellet appreciably under the ultracentrifugation conditions (45) .
Solid-State NMR Spectroscopy. Experiments were done on a 9.4 T spectrometer (Varian Infinity Plus) using a triple resonance MAS probe. The NMR detection channel was tuned to 13 C at 100.8 MHz, the decoupling channel was tuned to 1 H at 400.8 MHz, and the third channel was tuned to 15 N at 40.6 MHz. 13 C and 15 N chemical shifts were externally referenced to the methylene resonance of adamantane at 38.2 ppm and (NH 4 ) 2 SO 4 at 20 ppm, respectively. Experiments used a MAS frequency of 8000 ( 2 Hz. In the NMR probe circuit, the radio frequency (rf) fields are highly attenuated at the ends of the coil, and it was experimentally observed that nearly all of the NMR signal comes from the central two-third coil volume. Hence, for the FPK3 samples, longer spacers were used to restrict samples to this central volume (∼160 µL). For the other samples, the full volume of the rotor was used. Because the outer one-third volume contributes negligible signal, direct comparison could be made between all of the samples. The chief advantage of the volume restriction is lower sample requirement.
The experiments were performed at -50°C because, relative to room temperature, there is about three times greater signal per 13 C at the lower temperature. This result is likely in part due to more efficient cross-polarization (CP) because of reduced motion at lower temperature. 13 C backbone chemical shifts were similar at both temperatures, which suggests that cooling the sample does not cause significant peptide structural changes (50) .
In REDOR experiments to detect hydrogen bonds, between 1 and 2 ms of CP at 50 kHz was followed by a 24.0 ms dephasing period and then direct 13 C detection (62) . A single 50 kHz 13 C refocusing π pulse was placed at the center of the dephasing period, and 1 H TPPM decoupling of 65 kHz was applied during both dephasing and detection (79) . The 13 C transmitter was set to 155 ppm, and the 15 N transmitter was set to 115 ppm. For the S 1 acquisition, the dephasing period contained a 40 kHz 15 N π pulse at the middle and end of each rotor cycle, while the S 0 acquisition did not contain these pulses. XY-8 phase cycling was used for the 15 N pulses (80, 81) . This "all 15 N π pulse" version of REDOR was used for most of the experiments, but in some preliminary experiments, a different "alternating 15 N/ 13 C π pulse" version of REDOR was employed in which one 15 N and one 13 C π pulse were applied per rotor cycle during the dephasing period (63, 82) . For both REDOR versions, the difference between the S 0 and S 1 signal intensities is known as "dephasing" and is the experimental parameter used to determine 13 C-15 N dipolar couplings and distances. The spectrometer parameters were optimized with the lyophilized MB(i+4)EK-A9 C A13 N model helical peptide. Calibration of the 13 C π pulse length was done with a "Zfilter" sequence (CP-π/2-τ-π-acquire) in which 1 H decoupling was applied during the pulses and acquisition and for 10 µs at the beginning and end of the τ period. The 15 N π pulse was calibrated with minimization of the S 1 REDOR signal at 24.0 ms dephasing time. REDOR signals for the MB(i+4)EK-A9 C A13 N peptide were similar with or without active synchronization of the pulses to the rotor phase, and for the HIV-1 fusion peptide samples, pulses were not actively synchronized to the rotor phase. To obtain optimal compensation of B 0 , B 1 , and spinning frequency drifts, S 0 and S 1 FIDs were acquired alternately. The recycle delay was 1 s. The data were processed with 100 Hz line broadening and with fifth-order polynomial baseline correction.
For experiments designed to measure the Phe-8 carbonyl chemical shift of the LM3-associated FP-F8 C L9 N and FPK3-F8 C L9 N peptides, NMR spectra were taken using a REDOR filter of the directly bonded 13 C- 15 N dipolar interaction so that the Phe-8 carbonyl was the only signal observed in the 13 C-detected REDOR difference spectrum (48) . The experimental settings were similar to those of the previously described hydrogen bond REDOR experiments except that the dephasing time was set to 1.0 ms and a difference FID was obtained from S 0 -S 1 . The difference FID was processed with 50 Hz line broadening and with fifth-order polynomial baseline correction.
REDOR Data Analysis and Simulations. For the REDOR experiments designed to detect interpeptide hydrogen bonding, integration of signal intensities in the isotropic carbonyl regions of the S 0 and S 1 spectra yielded values which are denoted as "S 0 " and "S 1 ". ∆S/S 0 is a convenient normalized dephasing parameter for comparison of experiment and simulation and is defined as In addition, for each pair of S 0 /S 1 spectra, an experimental uncertainty σ was calculated as the root mean squared deviation of integrated intensities in 24 regions of the spectra without signal. σ ∆S/S 0 , the uncertainty in ∆S/S 0 , was calculated using the formula (83) Simulations of the REDOR experiment were carried out as a function of peptide structure and dephasing period using the SIMPSON program (84) . The experimental pulse sequence, MAS frequency, 13 C and 15 N rf fields and pulse lengths, and 15 N phases were incorporated into the simulations. Carbonyl chemical shift anisotropy (CSA) principal values were set to be 250, 190, and 90 ppm, and the principal axis directions were taken from the literature with the following orientations: δ 33 perpendicular to the peptide plane and δ 22 at an angle ) 130°from the C-N bond (85) . The calculated REDOR dephasing curves were approximately independent of the carbonyl CSA principal axis geometry, which is consistent with simulations in other studies (86) . 1 H were not considered in the simulations. For each simulation of a sample containing adjacent 13 C and 15 N triply labeled strands, either a parallel or antiparallel sheet geometry was assumed and was based on coordinates obtained from the crystal structure of the B1 domain of streptococcal protein G (PDB file 1igd) (87) . Each simulation also used a defined register of the 13 C-and 15 N-labeled residues in neighboring strands.
RESULTS
Similarity of FP, FPK3
, and FPK3W. For the influenza fusion peptide, addition of a lysine-rich "host sequence" at the C-terminus of the peptide improves the peptide solubility in aqueous solution (41, 88) . For some of our solid-state NMR samples, a similar modification was made for the HIV-1 fusion peptide (FPK3), and we wanted to establish that this addition did not have a significant effect on the peptide interaction with membranes. Lipid-mixing assays were carried out to assess peptide fusogenicities, and solidstate NMR measurements were used to probe local structure in the centers of the membrane-associated peptides. Figure 1e,f) . Because of the directly bonded 13 C- 15 N spin pairs in FP-F8 C L9 N and FPK3-F8 C L9 N , the Phe-8 carbonyl signals dominate the displayed REDORfiltered difference spectra, with quantitative attenuation of the natural abundance 13 C signals from lipid and peptide. In both spectra, the full-width at half-maximum line widths are ∼2.5 ppm, which is consistent with a relatively narrow conformational distribution at Phe-8, and the peak chemical shifts are ∼171 ppm, which is consistent with nonhelical local structure (89-93). The overall similarity of the lipidmixing data and NMR spectra for FP and FPK3 suggests that both peptides have comparable interactions with LM3 membranes. We note that previous solid-state NMR chemical shift and 2D exchange studies for LM3-associated FP were consistent with strand structure at other residues in the peptide as well (45) . Lipid-mixing and NMR studies were carried out on FPK3W-F8 C L9 N in LM3 and produced results similar to those shown in Figure 1 . In addition, analytical ultracentrifugation measurements demonstrated that a 90 µM solution of FPK3W in 5 mM HEPES, pH 7.0, is predominantly monomeric (data not shown). This result suggests that FPK3 is also a monomer in solution at the 10-60 µM concentrations used for preparation of solid-state NMR samples in the present study. Demonstration of monomeric behavior in solution is significant because it establishes that membranebound oligomers can be the result of peptide interactions at the membrane surface or in the membrane interior. The membrane-bound oligomers do not simply reflect the membrane deposition of oligomers which preexisted in aqueous solution.
Choice of REDOR Experiments. REDOR is a widely used solid-state NMR technique to probe heteronuclear dipolar couplings and distances (70) . In this study, REDOR was applied to identify interpeptide hydrogen bonding through detection of the 40-45 Hz 13 C-15 N dipolar coupling arising from an ∼4.1 Å [ 13 C]carbonyl-[ 15 N]amide distance. For the REDOR experiment, this is a rather weak coupling whose detection requires a dephasing period of 10-30 ms duration and hundreds of NMR π pulses. We therefore expended some effort in optimizing the REDOR experiment for detection of these hydrogen bonds. The main compound used for optimization was the lyophilized model helical peptide MB-(i+4)EK-A9 C A13 N .
The REDOR experiment relies on application of two π pulses per rotor cycle, and these could be both 13 C pulses or both 15 N pulses (all 15 N π pulse version) or one 15 N and one 13 C pulse (alternating 15 N/ 13 C π pulse version). When the alternating 15 N/ 13 C π pulse version of REDOR was applied to polycrystalline [1-13 C, 15 N]glycine and [2-13 C, 15 N]glycine samples, the experimental ∆S/S 0 values as a function of dephasing period fit well to simulations. When this version of REDOR was applied to the MB(i+4)EK-A9 C A13 N peptide, the experimental ∆S/S 0 values could also be fit well to simulations based on a structurally reasonable 4.1 Å 13 C- 15 N distance. Prior to fitting, the experimental ∆S/S 0 values were multiplied by a correction factor of magnitude 1.2-1.3, which accounted for the ∼15% population of random coil peptide in the sample, the small populations of labeled and natural abundance carbonyls which experience complete dephasing from neighboring natural abundance 15 N and labeled 15 N, respectively, and the remaining population of natural abundance carbonyls which do not dephase.
When the all 15 N π pulse version of REDOR was applied to the MB(i+4)EK-A9 C A13 N peptide, the corrected ∆S/S 0 values were less than those predicted by simulation. Variation of experimental parameters such as 15 N pulse shape did not have a significant impact on the experimental data. However, when the REDOR experiment was done in a 4 mm probe with 100 kHz TPPM 1 H decoupling, the data agreed much better with simulation. Reduction of decoupling to 70 kHz in the 4 mm probe gave ∆S/S 0 which was comparable to that found for the 6 mm probe with 65 kHz decoupling. Because ∆S/S 0 represents a normalized difference between FIDs with the same 1 H decoupling, it is not obvious why 1 H decoupling should affect ∆S/S 0 , but we note that there has been some controversy in the literature about the impact of 1 H decoupling and the ratio of 1 H to 15 N fields in REDOR and other dipolar recoupling experiments (94-99).
As displayed in Figure 2 , sensitivity was also an important factor in the REDOR experiment. For the all 15 N π pulse version of REDOR on a sample containing triply carbonyllabeled peptide, the S 0 signal at 24.0 ms dephasing time was about one-eighth that obtained with direct CP. With the alternating 13 C/ 15 N π pulse version of REDOR, there was additional attenuation by a factor of ∼0.6, which may be a result of π pulse SEDRA/RFDR recoupling of 13 C-13 C homonuclear interactions (100-102). In our study, REDOR was used as a semiquantitative probe of the extent of hydrogen bonding, and we chose to use the higher signalto-noise all 15 N π pulse version of REDOR. In general, as the dephasing period increases, ∆S/S 0 also increases, whereas the overall signal decreases. The chosen 24.0 ms dephasing period represents a compromise between these two competing effects.
REDOR Calibration and Control Experiments. Table 1 lists ∆S/S 0 values from a series of REDOR calibration and control experiments, and Figure 3 displays some of the corresponding experimental spectra. In our discussion of these results, " 13 C" and " 15 N" refer specifically to carbonyl carbons and amide nitrogens, respectively. The goal of the first experiment was calibration of ∆S/S 0 due to a 4.1 Å 13 C-15 N hydrogen-bonded pair. Using data from the lyophilized R helical MB(i+4)EK-A9 C A13 N peptide (cf. Figure 3a) , this value was estimated to be 0.45-0.50. This estimation included corrections for the small population of random coil peptide in the sample and the dephasing of natural abundance 13 C.
The goal of the remaining control experiments was to quantitate (∆S/S 0 ) background , which represents dephasing in the membrane-associated peptide samples which was not due to the labeled 13 C-15 N hydrogen-bonded pairs. For samples containing only 13 C-labeled and/or natural abundance peptide (cf. Figure 3b,d) , the ∆S/S 0 value is in the -0.01 to 0.03 range and is due to the 0.0037% 15 peptide, ∆S/S 0 ∼ 0.4. These relatively large ∆S/S 0 values are likely a result of the significant fraction of natural abundance carbonyls which are close to the labeled 15 N. For the samples used to probe fusion peptide strand arrangements, there was a 1:1 mixture of 13 C-and 15 N-labeled peptides and an ∼10% natural abundance peptide contribution to the total 13 C signal. In these samples, we would therefore expect an ∼0.02 contribution to ∆S/S 0 from natural abundance peptide 13 C.
In samples containing 50% [ 13 C]carbonyl-labeled lipid (LM4) and either 15 N-labeled peptide or unlabeled peptide, ∆S/S 0 ∼ 0.03 or 0.01, respectively (cf. Figure 3e) . In addition, when CP and S 0 intensities of these samples were compared to those of samples containing unlabeled lipid and 13 C-labeled peptide, it was observed that the CP signal per 13 C is about three times less for a lipid carbonyl than for a peptide carbonyl while the S 0 signal per 13 C is about nine times less for a lipid carbonyl than for a peptide carbonyl. By combining this latter result with the observation that ∆S/S 0 ∼ 0.4 for the sample containing unlabeled lipid and 15 Nlabeled peptide, it is possible to account for the ∆S/S 0 values in the [ 13 C]lipid-labeled samples by only considering dephasing of the natural abundance peptide carbonyl signal. This analysis suggests negligible dephasing of the lipid carbonyls.
The overall conclusion of the control experiments is that (∆S/S 0 ) background ∼ 0.03 for the LM3 samples with a 1:1 mixture of labeled 13 Four samples (cf. Figure 4a -d) were prepared to probe for the presence of an approximate in-register parallel arrangement of peptide strands. In each of these samples, the labeling in the 13 C peptide and in the 15 N peptide was at the same set of three sequential residues. With these four samples, interstrand hydrogen bonding of parallel strands was probed between Gly-5 and Gly-16. For the samples labeled between Gly-5 and Gly-13, the ∆S/S 0 values were in the 0.11-0.13 range, which is significantly above the 0.03 background value. For the sample containing peptide labeled between Ala-14 and Gly-16, ∆S/S 0 ∼ 0.03, which is the approximate background signal. Thus, it appears that there is a population of peptides with parallel arrangements of strands, and this arrangement frays apart toward the Cterminal side of the peptide. These results are schematically presented in Figure 5a and are consistent with a reasonable biophysical model based on the peptide sequence. In the sequence, the N-terminal and central regions only contain apolar residues while the C-terminal region contains a substantial fraction of polar or charged residues. For extended peptides in an oligomeric parallel strand arrangement, the apolar regions of all strands would be on one end of the oligomer and the polar regions would be on the other end -d) , the LM3 lipid mixture was used, and for the sample in (e), the LM4 lipid mixture was used. In LM3, 50 mol % of the lipid was unlabeled POPC, whereas in LM4, the POPC was replaced with [ 13 C]carbonyl-labeled DPPC. In (a-e), the S 0 spectrum is on the left and the S 1 spectrum is on the right, and the spectra were acquired without and with 15 N π pulses during the dephasing period, respectively. The dotted lines are included for visual comparison of the spectral intensities. These measurements were taken under the same conditions as described in Figure 1 except that the dephasing period was 24.0 ms and the number of scans for each spectrum (S 0 or S 1 ) was 256, 104352, 283024, 272000, and 85808 in (a-e), respectively. of the oligomer. The apolar end of the oligomer may insert into the membrane so that, in this region, the strands must hydrogen bond to one another, while the polar end of the oligomer is likely outside the membrane where the strands would hydrogen bond to water. This model is supported by previous measurements of carbonyl line widths along the peptide backbone (45) . In the N-terminal and central regions, the line widths are 2-3 ppm, which indicates a narrow distribution of secondary structures with a regular hydrogenbonding pattern, whereas in the C-terminal region, the line widths are ∼5 ppm, which indicates random coil structure and irregular hydrogen bonding.
Four samples (cf. Figure 4e ,f) were also prepared to probe for antiparallel arrangement of peptide strands. The midpoint of the arrangement was chosen to be between Gly-10 and Phe-11, which is about the middle of the peptide. For example, the sample used for Figure 4h contained peptide which was 13 C labeled at Ala-14, Ala-15, and Gly-16 and peptide which was 15 N labeled at Gly-5, Ala-6, and Leu-7. For these four "antiparallel arrangement" samples, the ∆S/ S 0 values were in the 0.08-0.16 range and were significantly above the background level. Thus, in addition to the previously described parallel strand population, there also appears to be an antiparallel strand population whose interpeptide hydrogen bonding continues at least from Gly-5 to Gly-16. This result is schematically presented in Figure  5b . For extended peptides in an oligomeric antiparallel strand arrangement, there would be both polar and apolar ends of N . Samples in (a-d) primarily probed the presence of parallel strand arrangements and samples in (e-h) primarily probed the presence of antiparallel strand arrangements. The dotted lines are included for visual comparison of the spectral intensities. These measurements were taken under the same conditions as described in Figure 1 except that the dephasing period was 24.0 ms and the number of scans for each spectrum (S 0 or S 1 ) was ∼100000 for FP peptide samples and ∼200000 for FPK3 peptide samples. strands on each end of the oligomer, which is qualitatively different than what is expected for a parallel strand arrangement. Because of this mixed polarity, it is less clear whether an antiparallel oligomer would insert into the membrane.
Because most samples which probed for parallel and antiparallel strand arrangements had comparable ∆S/S 0 values, it is likely that there are roughly equal populations of each arrangement. Such arrangements could exist for fully extended peptides in a sheet or barrel structure, or they could exist for peptides in a hairpin structure. There will be intrapeptide as well as interpeptide hydrogen bonding in the hairpin structure, and we are working to detect possible intrapeptide hydrogen bonding with a new set of 13 C-15 N REDOR experiments. For the present interpeptide hydrogenbonding study, we also considered whether ∆S/S 0 values predicted for a totally extended oligomeric strand model matched the experimental ∆S/S 0 values. If the experimental values are significantly less than the predicted values, then there may be a population of hairpin peptides with intrapeptide hydrogen bonding.
In the extended peptide model, we considered that the total S 0 carbonyl signal had contributions from labeled 13 C in the peptide, natural abundance 13 C in the peptide, and natural abundance 13 L to the total S 1 signal. In quantitating 13 C, one 13 C-labeled peptide, one 15 N-labeled peptide, and 50 lipid molecules are considered in the sample. The 13 C peptide has three labels, and S 0 C is set to 3.0. The following calculations were made for the other S 0 signals: For the S 0 N calculation, we considered the FPK3 peptide with 26 residues. As described in the REDOR Control Experiments section, S 1 L ≈ S 0 L . Considering the spectrum displayed in Figure 3c , we approximate that S 1 N ≈ 0.8 × S 0 N ) 0.431. Considering the spectrum displayed in Figure 3a and the correction factor described in the REDOR Control Experiments section, we expect that the ∆S/S 0 for a single hydrogen-bonded 13 C-15 N pair is in the range of 0.45-0.50. For the samples used in this study, the labeled 13 C could be dipole-coupled to a 15 N hydrogen bond partner on the neighboring strand and also dipole-coupled to the more distant labeled 15 N on this strand. Simulations of the REDOR experiment were performed with this four-spin sheet geometry (one 13 C + three 15 N) and showed that the two more distant 15 N increased ∆S/S 0 by ∼10% over that of a single 13 C-15 N pair. Combining the experimental and simulation results, we approximate that S 1 C ≈ 0.50S 0 C for the case where all three labeled 13 C on one strand are hydrogen bonded with 15 N on adjacent strands. Because the experimental samples contain a 1:1 mixture of 13 C-and 15 Nlabeled peptide, there is only 50% probability that a 13 Clabeled strand will be adjacent to a 15 N-labeled strand. Therefore, a corrected S 1 C ≈ 0.75S 0 C ) 2.25 was used in the calculations.
Using all of these results, the total ∆S/S 0 for the extended strand model was calculated:
As described in the REDOR Control Experiments section, (∆S/S 0 ) background ∼ 0.03, so the labeled 13 C-15 N hydrogen bond contribution to dephasing, (∆S/S 0 ) model , is ∼0.20.
Comparison with experimental data was made using results from the FPK3-(G5A6L7) C /FPK3-(G5A6L7) N /LM3 and the FPK3-(G5A6L7) C /FPK3-(A14A15A16) N /LM3 samples as measures of (∆S/S 0 ) expt-parallel and (∆S/S 0 ) expt-antiparallel , respectively. After subtracting (∆S/S 0 ) background from each of the experimental ∆S/S 0 , we obtain values of (∆S/S 0 ) expt-parallel ≈ 0.10 and (∆S/S 0 ) expt-antiparallel ≈ 0.08. The total hydrogenbonding component of ∆S/S 0 for the FPK3-(G5A6L7) C peptide, (∆S/S 0 ) expt , is ∼0.18, which is comparable to (∆S/ S 0 ) model . This result suggests that the extended oligomeric structures account for much of the membrane-associated peptide population. The 10-15% difference between (∆S/ S 0 ) model and (∆S/S 0 ) expt could be due to uncertainties in the experimental data and model, different alignments of peptide strands than the fully in-register arrangements used for the model, and/or a population of turn peptides with intrapeptide hydrogen bonding. Intrapeptide hydrogen bonding was not probed in the experiments of this study.
DISCUSSION
The structural plasticity of membrane-associated viral fusion peptides has been observed by several groups using a variety of experimental probes, and it is known that they can exist in well-structured helical or nonhelical forms (15, 103) . Other investigators have developed structural models for the helical form of the peptides based principally on solution NMR, ESR, and infrared data (38, 44, 52) . In the present study, we applied solid-state NMR internuclear distance measurements to develop a structural model for the nonhelical form of the membrane-associated HIV-1 fusion peptide. This work was based on previous solid-state NMR chemical shift and 2D exchange measurements, which showed that the peptide is predominantly nonhelical when associated with membranes whose lipid headgroup and cholesterol composition is close to that found in host cells of the virus (45) . One of the possible nonhelical structures (5) is oligomeric strands held together by interpeptide hydrogen bonding, and we did experiments to detect this type of structure. In membrane-associated fusion peptide samples containing A second important result is that the data were consistent with roughly equal populations of peptide in parallel or antiparallel strand arrangements. Interstrand hydrogen bonding was observed from Gly-5 through Gly-16 in the antiparallel arrangement but only from Gly-5 through Gly-13 in the parallel arrangement. C-terminal fraying in the parallel arrangement is consistent with previous solid-state NMR line width measurements and with a reasonable biophysical model in which the apolar N-terminal and central regions of the oligomer insert into the membrane while the polar C-terminal region is outside the membrane (45) . Experiments by other groups also suggest that the C-terminal region is not membrane-inserted, although some of these measurements suggest that this region is helical, rather than the random coil structure indicated by our previously published experiments (22) . These different structures may be a result of the different lengths of the C-terminal regions used in the different studies.
It is also useful to consider our results in the context of the expected fusion peptide topology in the gp41 protein.
Structures of the gp41 soluble ectodomain begin around residue 30 and are trimeric with the three N-termini in close proximity at the end of an in-register helical coiled-coil. These structures end several residues C-terminal of the fusion peptide, and it has been hypothesized that during viral/target cell fusion, at least three fusion peptides insert into the target cell membrane with their C-termini in close proximity (29) (30) (31) (32) 34) . In the HIV-1 fusion peptide model system, the biological topology has been mimicked with C-terminal cross-linking, and it has been observed that, in many cases, the cross-linked peptides induce both a greater final extent and a more rapid rate of fusion than their non-cross-linked analogues (49) . Similar fusogenic enhancements have been observed for influenza protein domains for which the fusion peptide is thought to assume the biologically relevant oligomeric topology (21, 38, 51, (104) (105) (106) (107) . In these contexts, it is appealing that a fusion peptide population was indeed observed in the present study with an approximately inregister parallel strand arrangement. This arrangement seems like a reasonable continuation of the known ectodomain oligomeric structure, and this arrangement also has a defined apolar region of the fusion peptide oligomer which could insert into the membrane and catalyze fusion. For the noncross-linked peptides used for the present study, a population of peptide with antiparallel strand arrangement was also observed. In the antiparallel arrangement, it is not as clear how the oligomer might insert into the membrane and catalyze fusion. Thus, the fusogenic enhancement of the HIV-1 cross-linked peptides may be in part due to their preference for a parallel strand arrangement. One approach to testing this model would be to cross-link 13 C-and 15 Nlabeled peptides and perform interstrand REDOR measurements similar to those described in this paper. Detection of larger ∆S/S 0 for parallel strand labeling schemes relative to antiparallel schemes would provide experimental evidence for the model.
Formation of parallel and antiparallel strand arrangements for the membrane-associated HIV-1 fusion peptide appears to be qualitatively different from what has been found for peptides in solid amyloid fibrils. In amyloid, a single peptide sequence appears to form either a parallel or an antiparallel strand arrangement (65, (108) (109) (110) .
The present study also provides some insight into oligomer formation. Analytical ultracentrifugation data strongly suggest that the 26-residue FPK3 construct is predominantly monomeric in the buffer solution, so formation of membraneassociated strand oligomers can be a direct result of peptide/membrane interaction. In addition, the analytical ultracentrifugation data suggest that the 23-residue FP construct forms a mixture of oligomeric states in the buffer solution. In the initial step of FP solid-state NMR sample preparation, separate solutions of 13 C-and 15 N-labeled peptide were made and contained either 13 C or 15 N oligomers. After FP/membrane association, the solid-state NMR REDOR data showed significant ∆S/S 0 values (comparable to those of FPK3 samples), which means that the membrane-associated FP oligomers were a molecular mixture of 13 C-and 15 Nlabeled peptides. This transformation from separated to mixed oligomers could have been a result of exchange in aqueous solution. However, the 13 C and 15 N peptide solutions were mixed only briefly prior to addition of liposomes, and we believe that it is more likely that the FP oligomers disassemble and reassemble upon interaction with the membrane. This disassembly/reassembly model is consistent with the experimental observation that an influenza fusion peptide which is oligomeric in aqueous solution can be converted to a helical structure upon membrane binding (48, 88) . It is also consistent with ideas and experiments from other groups (20, 42) ; in particular, the fusogenically disruptive Val-2 to Glu-2 point mutation in the HIV-1 fusion peptide was correlated with formation of peptide dimers rather than the larger oligomers found for the wild-type peptide (16) . It was therefore hypothesized that the mutant peptide prevented the proper membrane-mediated assembly of peptides required for fusion activity.
There are several remaining questions about the structures of membrane-associated oligomeric strand HIV-1 fusion peptides including (1) the relative populations of hairpin and extended structures, (2) the effect of the biologically relevant oligomeric topology on the relative populations of parallel and antiparallel strand arrangements, (3) the overall oligomer size and the number of peptides with a particular strand arrangement, (4) the precise residue register(s) between neighboring strands in a particular arrangement, (5) the insertion of the oligomer into the membrane, and (6) and the overall oligomer structure which satisfies hydrogen bonding for most of the carbonyl oxygens and amide protons. Question 5 has been previously investigated with fluorescence and ESR measurements, but the data analyses may have been complicated by the presence of parallel and antiparallel oligomers which may have different insertion depths (16, 35, 111) . Larger biological questions include the relative fusogenicities of the helical and nonhelical forms of the peptide and the possible role of transient structures in fusion catalysis. At least for the influenza fusion peptide, it appears that both helical and nonhelical forms are fusogenic and that there is not a single transient fusogenic structure. The relative populations of helical and nonhelical peptide structures are significantly affected by the lipid and cholesterol composition of the target membrane (88) . A combination of experiments, simulation, and modeling will likely be necessary to understand the specific peptide/lipid and peptide/ cholesterol interactions which determine the overall peptide structure (52, 55, 112) .
In summary, solid-state NMR has been applied to detect oligomeric strand structure in the membrane-associated HIV-1 fusion peptide. A roughly equal mixture of parallel and antiparallel strand arrangements was observed with fraying of the strands toward the C-terminus in the parallel arrangement. These studies provide a basis to develop a more refined model of the peptide structure and to understand how it may catalyze membrane fusion.
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